ResMed Inc
RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3012% below fair value
$235.63−1.25 (-0.53%)
Close on Nov 20, 2026Market cap $33.14BP/E 21.5Yield 1.02%
ResMed Net Cash Provided by Investing Activities
Net Cash Provided by (Used in) Investing Activities ($M) ($M)
ResMed Net Cash Provided by Investing Activities: $392M in Q1 FY27, down 845.4% from a year earlier. That is the highest of the 69 quarters on record here.
Latest, Q1 FY27
392
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
-845.4%
-52.6 in Q1 FY26
History
69 quarters
Since Q1 FY10
Sources
64
Documents cited below
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net Cash Provided by (Used in) Investing Activities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q1 FY27CQ3 2026 | Sep 30, 2026 | 392 | -845.4% | – |
| Q4 FY26CQ2 2026 | Jun 30, 2026 | -384 | +187.0% | ResMed SEC Filing (0000943819-26-000047) ↗ |
| Q3 FY26CQ1 2026 | Mar 31, 2026 | -58 | +82.4% | ResMed SEC Filing (0000943819-26-000025) ↗ |
| Q2 FY26CQ4 2025 | Dec 31, 2025 | -50.9 | +38.7% | ResMed SEC Filing (0000943819-26-000007) ↗ |
| Q1 FY26CQ3 2025 | Sep 30, 2025 | -52.6 | -2,604.8% | ResMed SEC Filing (0000943819-25-000090) ↗ |
| Q4 FY25CQ2 2025 | Jun 30, 2025 | -134 | +187.5% | ResMed SEC Filing (0000943819-25-000035) ↗ |
| Q3 FY25CQ1 2025 | Mar 31, 2025 | -31.8 | -4.2% | ResMed SEC Filing (0000943819-25-000008) ↗ |
| Q2 FY25CQ4 2024 | Dec 31, 2024 | -36.7 | -10.7% | ResMed SEC Filing (0000943819-25-000004) ↗ |
| Q1 FY25CQ3 2024 | Sep 30, 2024 | 2.10 | -101.4% | ResMed SEC Filing (0000943819-24-000027) ↗ |
| Q4 FY24CQ2 2024 | Jun 30, 2024 | -46.5 | 0.0% | ResMed SEC Filing (0000943819-24-000013) ↗ |
| Q3 FY24CQ1 2024 | Mar 31, 2024 | -33.2 | +18.1% | ResMed SEC Filing (0000943819-24-000008) ↗ |
| Q2 FY24CQ4 2023 | Dec 31, 2023 | -41.1 | -96.0% | ResMed SEC Filing (0000943819-24-000003) ↗ |
| Q1 FY24CQ3 2023 | Sep 30, 2023 | -149 | +153.4% | ResMed SEC Filing (0000943819-23-000029) ↗ |
| Q4 FY23CQ2 2023 | Jun 30, 2023 | -46.5 | -15.8% | ResMed SEC Filing (0000943819-23-000011) ↗ |
| Q3 FY23CQ1 2023 | Mar 31, 2023 | -28.1 | -43.2% | ResMed SEC Filing (0000943819-23-000008) ↗ |
| Q2 FY23CQ4 2022 | Dec 31, 2022 | -1,026 | +1,132.2% | ResMed SEC Filing (0000943819-23-000003) ↗ |
| Q1 FY23CQ3 2022 | Sep 30, 2022 | -58.8 | +40.3% | ResMed SEC Filing (0000943819-22-000019) ↗ |
| Q4 FY22CQ2 2022 | Jun 30, 2022 | -55.2 | +14.8% | ResMed SEC Filing (0000943819-22-000010) ↗ |
| Q3 FY22CQ1 2022 | Mar 31, 2022 | -49.5 | -15.5% | ResMed SEC Filing (0000943819-22-000006) ↗ |
| Q2 FY22CQ4 2021 | Dec 31, 2021 | -83.3 | +180.5% | ResMed SEC Filing (0000943819-22-000003) ↗ |
| Q1 FY22CQ3 2021 | Sep 30, 2021 | -41.9 | +89.6% | ResMed SEC Filing (0000943819-21-000031) ↗ |
| Q4 FY21CQ2 2021 | Jun 30, 2021 | -48.1 | +1,314.7% | ResMed SEC Filing (0000943819-21-000017) ↗ |
| Q3 FY21CQ1 2021 | Mar 31, 2021 | -58.6 | -41.2% | ResMed Form 10-Q (filed 2021-04-30) ↗ |
| Q2 FY21CQ4 2020 | Dec 31, 2020 | -29.7 | -31.9% | ResMed Form 10-Q (filed 2021-01-29) ↗ |
| Q1 FY21CQ3 2020 | Sep 30, 2020 | -22.1 | -33.4% | ResMed Form 10-Q (filed 2020-10-30) ↗ |
| Q4 FY20CQ2 2020 | Jun 30, 2020 | -3.40 | -92.3% | ResMed Form 10-K (filed 2020-08-13) ↗ |
| Q3 FY20CQ1 2020 | Mar 31, 2020 | -99.6 | -55.8% | ResMed Form 10-Q (filed 2020-05-01) ↗ |
| Q2 FY20CQ4 2019 | Dec 31, 2019 | -43.6 | -93.4% | ResMed Form 10-Q (filed 2020-01-31) ↗ |
| Q1 FY20CQ3 2019 | Sep 30, 2019 | -33.2 | -77.6% | ResMed Form 10-Q (filed 2019-10-25) ↗ |
| Q4 FY19CQ2 2019 | Jun 30, 2019 | -43.9 | +14.0% | ResMed Form 10-K (filed 2019-08-08) ↗ |
| Q3 FY19CQ1 2019 | Mar 31, 2019 | -225 | +1,050.0% | ResMed Form 10-Q (filed 2019-05-03) ↗ |
| Q2 FY19CQ4 2018 | Dec 31, 2018 | -658 | +2,225.8% | ResMed Form 10-Q (filed 2019-02-01) ↗ |
| Q1 FY19CQ3 2018 | Sep 30, 2018 | -148 | +862.3% | ResMed Form 10-Q (filed 2018-10-26) ↗ |
| Q4 FY18CQ2 2018 | Jun 30, 2018 | -38.5 | +23.0% | ResMed Form 10-K (filed 2018-08-17) ↗ |
| Q3 FY18CQ1 2018 | Mar 31, 2018 | -19.6 | +9.5% | ResMed Form 10-Q (filed 2018-04-27) ↗ |
| Q2 FY18CQ4 2017 | Dec 31, 2017 | -28.3 | +45.1% | ResMed Form 10-Q (filed 2018-01-24) ↗ |
| Q1 FY18CQ3 2017 | Sep 30, 2017 | -15.4 | +16.7% | ResMed Form 10-Q (filed 2017-10-27) ↗ |
| Q4 FY17CQ2 2017 | Jun 30, 2017 | -31.3 | -96.2% | ResMed Form 10-K (filed 2017-08-04) ↗ |
| Q3 FY17CQ1 2017 | Mar 31, 2017 | -17.9 | -78.6% | ResMed Form 10-Q (filed 2017-04-28) ↗ |
| Q2 FY17CQ4 2016 | Dec 31, 2016 | -19.5 | -87.9% | ResMed Form 10-Q (filed 2017-01-25) ↗ |
| Q1 FY17CQ3 2016 | Sep 30, 2016 | -13.2 | -78.9% | ResMed Form 10-Q (filed 2016-10-28) ↗ |
| Q4 FY16CQ2 2016 | Jun 30, 2016 | -818 | +3,381.7% | ResMed Form 10-K (filed 2016-08-05) ↗ |
| Q3 FY16CQ1 2016 | Mar 31, 2016 | -83.7 | +340.5% | ResMed Form 10-Q (filed 2016-04-29) ↗ |
| Q2 FY16CQ4 2015 | Dec 31, 2015 | -161 | +173.1% | ResMed Form 10-Q (filed 2016-01-28) ↗ |
| Q1 FY16CQ3 2015 | Sep 30, 2015 | -62.7 | +50.7% | ResMed Form 10-Q (filed 2015-10-27) ↗ |
| Q4 FY15CQ2 2015 | Jun 30, 2015 | -23.5 | +3.1% | ResMed Form 10-K (filed 2015-08-07) ↗ |
| Q3 FY15CQ1 2015 | Mar 31, 2015 | -19 | -18.1% | ResMed Form 10-Q (filed 2015-04-29) ↗ |
| Q2 FY15CQ4 2014 | Dec 31, 2014 | -59 | +115.3% | ResMed Form 10-Q (filed 2015-01-30) ↗ |
| Q1 FY15CQ3 2014 | Sep 30, 2014 | -41.6 | +92.6% | ResMed Form 10-Q (filed 2014-10-31) ↗ |
| Q4 FY14CQ2 2014 | Jun 30, 2014 | -22.8 | -14.0% | ResMed Form 10-K (filed 2014-08-08) ↗ |
| Q3 FY14CQ1 2014 | Mar 31, 2014 | -23.2 | +10.5% | ResMed Form 10-Q (filed 2014-05-01) ↗ |
| Q2 FY14CQ4 2013 | Dec 31, 2013 | -27.4 | +76.8% | ResMed Form 10-Q (filed 2014-01-29) ↗ |
| Q1 FY14CQ3 2013 | Sep 30, 2013 | -21.6 | +44.0% | ResMed Form 10-Q (filed 2013-10-30) ↗ |
| Q4 FY13CQ2 2013 | Jun 30, 2013 | -26.5 | +223.2% | ResMed Form 10-K (filed 2013-08-13) ↗ |
| Q3 FY13CQ1 2013 | Mar 31, 2013 | -21 | +262.1% | ResMed Form 10-Q (filed 2013-05-01) ↗ |
| Q2 FY13CQ4 2012 | Dec 31, 2012 | -15.5 | -3.1% | ResMed Form 10-Q (filed 2013-01-31) ↗ |
| Q1 FY13CQ3 2012 | Sep 30, 2012 | -15 | -79.1% | ResMed Form 10-Q (filed 2012-10-31) ↗ |
| Q4 FY12CQ2 2012 | Jun 30, 2012 | -8.20 | -45.7% | ResMed Form 10-K (filed 2012-08-14) ↗ |
| Q3 FY12CQ1 2012 | Mar 31, 2012 | -5.80 | -60.3% | ResMed Form 10-Q (filed 2012-05-01) ↗ |
| Q2 FY12CQ4 2011 | Dec 31, 2011 | -16 | +0.6% | ResMed Form 10-Q (filed 2012-02-02) ↗ |
| Q1 FY12CQ3 2011 | Sep 30, 2011 | -71.7 | +132.0% | ResMed Form 10-Q (filed 2011-11-03) ↗ |
| Q4 FY11CQ2 2011 | Jun 30, 2011 | -15.1 | +5.6% | ResMed Form 10-K (filed 2011-08-17) ↗ |
| Q3 FY11CQ1 2011 | Mar 31, 2011 | -14.6 | +55.3% | ResMed Form 10-Q (filed 2011-05-03) ↗ |
| Q2 FY11CQ4 2010 | Dec 31, 2010 | -15.9 | -25.0% | ResMed Form 10-Q (filed 2011-02-03) ↗ |
| Q1 FY11CQ3 2010 | Sep 30, 2010 | -30.9 | +130.6% | ResMed Form 10-Q (filed 2010-11-03) ↗ |
| Q4 FY10CQ2 2010 | Jun 30, 2010 | -14.3 | – | ResMed Form 10-K (filed 2011-08-17) ↗ |
| Q3 FY10CQ1 2010 | Mar 31, 2010 | -9.40 | – | ResMed Form 10-Q (filed 2011-05-03) ↗ |
| Q2 FY10CQ4 2009 | Dec 31, 2009 | -21.2 | – | ResMed Form 10-Q (filed 2011-02-03) ↗ |
| Q1 FY10CQ3 2009 | Sep 30, 2009 | -13.4 | – | ResMed Form 10-Q (filed 2010-11-03) ↗ |
Cite this data
StockData. (2026). ResMed Net Cash Provided by Investing Activities ($M), quarterly Q1 FY10–Q1 FY27 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/db-cf-icf
See every metric in the ResMed KPI table. Data updated Nov 8, 2026.
See a number that looks wrong?